# Linkou Chang Gung Memorial Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/linkou-chang-gung-memorial-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 45.7 |
| Citations | 692,981 |
| City | Taoyuan |
| Country | TW |
| Description | Linkou Chang Gung Memorial Hospital is a research organisation in Taoyuan, TW. OpenAlex records 12,820 works and 692,981 citations for it. 4,254 researchers list it as their most recent affiliation. |
| Homepage | https://www.cgmh.org.tw/eng/about/system/4 |
| OpenAlex ID | https://openalex.org/I4210116208 |
| Region | Taiwan |
| Researchers | 4,254 |
| ROR ID | https://ror.org/02dnn6q67 |
| Type | healthcare |
| Wikidata ID | Q30297120 |
| Works | 12,820 |

## University papers

Showing 12 of 19.

- [Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update](https://scholariq.org/papers/asian-pacific-clinical-practice-guidelines-on-the-management-of-hepatitis-b-a/)
- [Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors](https://scholariq.org/papers/sunitinib-malate-for-the-treatment-of-pancreatic-neuroendocrine-tumors/)
- [Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study](https://scholariq.org/papers/global-prevalence-and-genotype-distribution-of-hepatitis-c-virus-infection-in/)
- [Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/pembrolizumab-in-combination-with-gemcitabine-and-cisplatin-compared-with/)
- [Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study](https://scholariq.org/papers/global-change-in-hepatitis-c-virus-prevalence-and-cascade-of-care-between-2015/)
- [Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study](https://scholariq.org/papers/randomized-phase-iii-study-of-gemcitabine-plus-s-1-s-1-alone-or-gemcitabine/)
- [A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)](https://scholariq.org/papers/a-randomized-phase-iii-trial-to-evaluate-rucaparib-monotherapy-as-maintenance/)
- [The Chang Gung Research Database—A multi‐institutional electronic medical records database for real‐world epidemiological studies in Taiwan](https://scholariq.org/papers/the-chang-gung-research-database-a-multi-institutional-electronic-medical/)
- [Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients](https://scholariq.org/papers/four-year-entecavir-therapy-reduces-hepatocellular-carcinoma-cirrhotic-events/)
- [Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer☆](https://scholariq.org/papers/randomized-trial-of-surgical-staging-extraperitoneal-or-laparoscopic-versus/)
- [Recurrent squamous cell carcinoma of cervix after definitive radiotherapy](https://scholariq.org/papers/recurrent-squamous-cell-carcinoma-of-cervix-after-definitive-radiotherapy/)
- [Fertility‐preserving treatment in young patients with endometrial adenocarcinoma](https://scholariq.org/papers/fertility-preserving-treatment-in-young-patients-with-endometrial-adenocarcinoma/)

## University researchers

- [Hung‐Hsueh Chou](https://scholariq.org/researchers/hung-hsueh-chou/)

## University top topics

Showing 8 of 25.

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Pelvic floor disorders treatments](https://scholariq.org/topics/pelvic-floor-disorders-treatments/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
